Differentiation-independent retinoid induction of folate receptor type β, a potential tumor target in myeloid leukemia

Blood

Volumn 96, Issue 10, 2000, Pages 3529-3536

  Wang, H ^a   Zheng, X ^a   Behm, F G ^a   Ratnam, M ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CELL NUCLEUS RECEPTOR; DEXAMETHASONE; FOLIC ACID; PHORBOL ESTER; RECEPTOR SUBTYPE; RETINOIC ACID; RETINOID; RETINOID X RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CONTROLLED STUDY; DNA FLANKING REGION; GENE EXPRESSION; GENE INDUCTION; GENE TARGETING; HUMAN; HUMAN CELL; LIGAND BINDING; MESSENGER RNA SYNTHESIS; MYELOID LEUKEMIA; PRIORITY JOURNAL; PROMOTER REGION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

EID: 0034670039     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.10.3529     Document Type: Article

References (51)

1. Complementary DNA for the folate binding protein correctly predicts anchoring to the membrane by glycosyl-phosphatidylinositol
2. Homologous membrane folate binding proteins in human placenta: Cloning and sequence of a cDNA
3. Folate receptor type γ is primarily a secretory protein due to lack of an efficient signal for glycosylphosphatidylinositol modification: Protein characterization and cell type specificity
4. Expression levels of functional folate receptors-α and-β are related to the number of N-glycosylated sites
5. Preferred sites of glycosylphosphatidylinositol modification in folate receptors and constraints in the primary structure of the hydrophobic portion of the signal
6. Endocytosis of folate-protein conjugates: Ultrastructural localization in KB cells
7. Delivery of macromolecules into living cells: A method that exploits relate receptor endocytosis
8. Distribution of the folate receptor GP38 in normal and malignant cell lines and tissue
9. Differential regulation of relate receptor isoforms in normal and malignant tissues in vivo and in established cell lines: Physiologic and clinical implications
10. Expression of folate receptor type α in relation to cell type, malignancy, and differentiation in ovary, uterus, and cervix
11. Folate-mediated targeting of therapeutic and imaging agents to cancers
12. Folate receptor type β is a neutrophilic lineage marker and is differentially expressed in myeloid leukemia
13. Selective expression of folate receptor β and its possible rote in methotrexate transport in synovial macrophages from patients with rheumatoid arthritis
14. The heterogeneity and properties of folate binding proteins from chronic myelogenous leukemia cells
15. Identification of a novel relate receptor, a truncated receptor, and receptor type β in hematopoietic cells: cDNA cloning, expression, immunoreactivity, and tissue specificity
16. + cells
17. Mice lacking the folic acid-binding protein Folbp1 are defective in early embryonic development
18. Therapy of acute promyelocytic leukemia: All-trans retinoic acid and beyond
19. Acute promyelocytic leukemia: A curable disease
20. Differential stereospecificities and affinities of folate receptor isoforms for folate compounds and antifolates
21. Establishment and characterization of a novel acute promyelocytic leukemia cell line (UF-1) with retinoic acid-resistant features
22. The phorbol ester, 12-O-tetradecanoyl-phorbol-13-acetate, induces specific transcription by RNA polymerase III in Drosophila Schneider cells
23. Structure and regulation of a polymorphic gene encoding relate receptor type γ/γ'
24. Expression of retinoic acid receptor alpha mRNA in human leukemia cells
25. Characterization of the gene encoding a relate-binding protein expressed in human placenta
26. Human myeloid leukemia cell lines: A review
27. Retinoic acid enhances colony-stimulating factor-induced clonal growth of normal human myeloid progenitor cells in vitro
28. Induction of differentiation of human myeloid leukemias: Surface changes probed with monoclonal antibodies
29. Phorbol ester effect on differentiation of human myeloid leukemia cell lines blocked at different stages of maturation
30. Induction of differentiation in blast cells and leukemia colony-forming cells from patients with acute myeloid leukemia
31. 3 receptors
32. A direct repeat in the cellular retinol-binding protein type II gene confers differential regulation by RXR and RAR
33. Similarity of folate receptor expression in UMSCC 38 cells to squameus cell carcinoma differentiation markers
34. Retinoic acid-dependent upregulation of mouse folate receptor-α, expression in embryonic stem cells, and conservation of alternative splicing patterns
35. Deconstructing a disease: RARα, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia
36. Acute promyelocytic leukemia as a model for cross-talk between interferon and retinoic acid pathways: From molecular biology to clinical applications
37. Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: Implications for relapse and retinoid 'resistance' in patients with acute promyelocytic leukemia
38. Resistance to all-trans retinoic acid (ATRA) therapy in relapsing acute promyelocytic leukemia: Study of in vitro ATRA sensitivity and cellular retinoic acid binding protein levels in leukemic cells
39. In vitro alltrans retinoic acid (ATRA) sensitivity and cellular retinoic acid binding protein (CRABP) levels in relapse leukemic cells after remission induction by ATRA in acute promyelocytic leukemia
40. Retinoid resistance in acute promyelocytic leukemia: New mechanisms, strategies and implications
41. Inhibition of trans-retinoic acid-resistant human breast cancer cell growth by retinoid X receptor-selective retinoids
42. Targeting of PML/RARα is lethal to retinoic acid-resistant promyelocytic leukemia cells
43. Constitutive degradation of PML/RARα through the proteasome pathway mediates retinoic acid resistance
44. The occurrence of resistance to retinoic acid in the acute promyelocytic leukemia cell line NB4 is associated with altered expression of the PML/RAR alpha protein
45. Alteration in expression, binding to ligand and DNA, and transcriptional activity of rearranged and wild-type retinoid receptors in retinoid-resistant acute promyelocytic leukemia cell lines
46. A retinoid-resistant acute promyelocytic leukemia subclone expresses a dominant negative PML-RARα mutation
47. Role of the histone deacetylase complex in acute promyelocytic leukaemia
48. Mutations in the E-domain of RARα portion of the PML/RARα chimeric gene may confer clinical resistance to all-trans retinoic acid in acute promyelocytic leukemia
49. 9-cis-retinoic acid: Effects on normal and leukemic hematopoiesis in vitro
50. A new class of retinoids with selective inhibition of AP-1 inhibits proliferation
51. Alterations of differentiation, clonal proliferation, cell cycle progression and bcl-2 expression in RARα-altered sublines of HL-60